Trine Vik Lagerberg
- Post doc, Head of Unit; PhD
- +47 230 27350
Publications 2024
An epigenetic candidate-gene association study of parental styles in suicide attempters with substance use disorders
Addict Biol, 29 (4), e13392
DOI 10.1111/adb.13392, PubMed 38564607
Sex differences in autonomic adverse effects related to antipsychotic treatment and associated hormone profiles
Schizophrenia (Heidelb), 10 (1), 6
DOI 10.1038/s41537-023-00430-4, PubMed 38182592
Behind the heterogeneity in the long-term course of first-episode psychosis: Different psychotic symptom trajectories are associated with different patterns of cannabis and stimulant use
Schizophr Res, 271, 91-99
DOI 10.1016/j.schres.2024.07.006, PubMed 39018985
Neurocognitive function and delusion severity in schizophrenia spectrum disorders
Schizophr Res, 270, 172-177
DOI 10.1016/j.schres.2024.06.028, PubMed 38917554
Mismatch negativity and polygenic risk scores for schizophrenia and bipolar disorder
Schizophr Res, 264, 314-326
DOI 10.1016/j.schres.2024.01.013, PubMed 38215567
Childhood trauma and treatment resistance in first-episode psychosis: Investigating the role of premorbid adjustment and duration of untreated psychosis
Schizophr Res, 270, 441-450
DOI 10.1016/j.schres.2024.07.001, PubMed 38991420
Publications 2023
Predictors of Functional Impairment in Bipolar Disorder: Results From 13 Cohorts From Seven Countries by the Global Bipolar Cohort Collaborative
Focus (Am Psychiatr Publ), 21 (4), 444-452
DOI 10.1176/appi.focus.23021021, PubMed 38694997
The relationship between cannabis use, schizophrenia, and bipolar disorder: a genetically informed study
Lancet Psychiatry, 10 (6), 441-451
DOI 10.1016/S2215-0366(23)00143-8, PubMed 37208114
Nicotine use and non-pathological alcohol use and their relationship to affective symptoms and sleep disturbances in bipolar disorder
J Affect Disord, 327, 236-243
DOI 10.1016/j.jad.2023.02.003, PubMed 36746243
Impulsivity across severe mental disorders: a cross-sectional study of immune markers and psychopharmacotherapy
BMC Psychiatry, 23 (1), 659
DOI 10.1186/s12888-023-05154-4, PubMed 37674162
The trajectory of two negative symptom dimensions in first-episode psychosis and the role of cannabis use: A 10-year follow-up study
Schizophr Res, 252, 317-325
DOI 10.1016/j.schres.2023.01.024, PubMed 36706477
A transdiagnostic approach to negative symptoms: exploring factor structure and negative symptoms in bipolar disorders
Front Psychiatry, 14, 1136097
DOI 10.3389/fpsyt.2023.1136097, PubMed 37398600
Tobacco smoking related to childhood trauma mediated by cognitive control and impulsiveness in severe mental disorders
Schizophr Res, 261, 236-244
DOI 10.1016/j.schres.2023.09.041, PubMed 37806047
Visual processing deficits in patients with schizophrenia spectrum and bipolar disorders and associations with psychotic symptoms, and intellectual abilities
Heliyon, 9 (2), e13354
DOI 10.1016/j.heliyon.2023.e13354, PubMed 36825178
Telomere length and verbal learning in bipolar disorders
J Affect Disord, 339, 555-560
DOI 10.1016/j.jad.2023.07.087, PubMed 37459977
Mismatch negativity in schizophrenia spectrum and bipolar disorders: Group and sex differences and associations with symptom severity
Schizophr Res, 261, 80-93
DOI 10.1016/j.schres.2023.09.012, PubMed 37716205
Relationship between function and structure in the visual cortex in healthy individuals and in patients with severe mental disorders
Psychiatry Res Neuroimaging, 332, 111633
DOI 10.1016/j.pscychresns.2023.111633, PubMed 37028226
Auditory Cortex Thickness Is Associated With N100 Amplitude in Schizophrenia Spectrum Disorders
Schizophr Bull Open, 4 (1), sgad015
DOI 10.1093/schizbullopen/sgad015, PubMed 38812720
Early identification of treatment non-response in first-episode psychosis
Eur Psychiatry, 66 (1), e30
DOI 10.1192/j.eurpsy.2023.15, PubMed 36915260
Publications 2022
Locked out during COVID-19 lockdown-an online survey of relatives of people with psychotic and bipolar disorders in Norway
BMC Public Health, 22 (1), 294
DOI 10.1186/s12889-022-12625-y, PubMed 35151293
Lifetime and point prevalence of psychotic symptoms in adults with bipolar disorders: a systematic review and meta-analysis
Psychol Med, 52 (13), 2413-2425
DOI 10.1017/S003329172200201X, PubMed 36016504
The COVID-19 pandemic impact on wellbeing and mental health in people with psychotic and bipolar disorders
Brain Behav, 12 (5), e2559
DOI 10.1002/brb3.2559, PubMed 35385888
Developing "MinDag" - an app to capture symptom variation and illness mechanisms in bipolar disorder
Front Med Technol, 4, 910533
DOI 10.3389/fmedt.2022.910533, PubMed 35935144
Predictors of functional impairment in bipolar disorder: Results from 13 cohorts from seven countries by the global bipolar cohort collaborative
Bipolar Disord, 24 (7), 709-719
DOI 10.1111/bdi.13208, PubMed 35322518
Composite immune marker scores associated with severe mental disorders and illness course
Brain Behav Immun Health, 24, 100483
DOI 10.1016/j.bbih.2022.100483, PubMed 35856063
Plasma Levels of the Cytokines B Cell-Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL) in Schizophrenia, Bipolar, and Major Depressive Disorder: A Cross Sectional, Multisite Study
Schizophr Bull, 48 (1), 37-46
DOI 10.1093/schbul/sbab106, PubMed 34499169
The shared genetic basis of mood instability and psychiatric disorders: A cross-trait genome-wide association analysis
Am J Med Genet B Neuropsychiatr Genet, 189 (6), 207-218
DOI 10.1002/ajmg.b.32907, PubMed 35841185
Affective lability and social functioning in severe mental disorders
Eur Arch Psychiatry Clin Neurosci, 272 (5), 873-885
DOI 10.1007/s00406-022-01380-1, PubMed 35084540
Preventive Medication Patterns in Bipolar Disorder and Their Relationship With Comorbid Substance Use Disorders in a Cross-National Observational Study
Front Psychiatry, 13, 813256
DOI 10.3389/fpsyt.2022.813256, PubMed 35592382
Genetic overlap between mood instability and alcohol-related phenotypes suggests shared biological underpinnings
Neuropsychopharmacology, 47 (11), 1883-1891
DOI 10.1038/s41386-022-01401-6, PubMed 35953530
Sex differences in antipsychotic-related triglyceride levels are associated with metabolic hormone differences in patients with severe mental disorders
Schizophr Res, 243, 55-63
DOI 10.1016/j.schres.2022.02.015, PubMed 35240428
Sex-specific associations between metabolic hormones, severe mental disorders and antipsychotic treatment
Psychoneuroendocrinology, 146, 105927
DOI 10.1016/j.psyneuen.2022.105927, PubMed 36152455
COVID-19 lockdown - who cares? The first lockdown from the perspective of relatives of people with severe mental illness
BMC Public Health, 22 (1), 1104
DOI 10.1186/s12889-022-13458-5, PubMed 35655294
Systemic Cell Adhesion Molecules in Severe Mental Illness: Potential Role of Intercellular CAM-1 in Linking Peripheral and Neuroinflammation
Biol Psychiatry, 93 (2), 187-196
DOI 10.1016/j.biopsych.2022.06.029, PubMed 36182530
Inflammation and cognition in severe mental illness: patterns of covariation and subgroups
Mol Psychiatry, 28 (3), 1284-1292
DOI 10.1038/s41380-022-01924-w, PubMed 36577840
Retrospectively assessed childhood trauma experiences are associated with illness severity in mental disorders adjusted for symptom state
Psychiatry Res, 320, 115045
DOI 10.1016/j.psychres.2022.115045, PubMed 36621206
Publications 2021
Sex-Specific Effect of Serum Lipids and Body Mass Index on Psychotic Symptoms, a Cross-Sectional Study of First-Episode Psychosis Patients
Front Psychiatry, 12, 723158
DOI 10.3389/fpsyt.2021.723158, PubMed 34744818
Characterization of affective lability across subgroups of psychosis spectrum disorders
Int J Bipolar Disord, 9 (1), 34
DOI 10.1186/s40345-021-00238-0, PubMed 34734342
Exploring the relationship between recency and frequency of cannabis use and diminished expression and apathy as two dimensions of negative symptoms in first episode psychosis. A one-year follow-up study
Schizophr Res, 236, 89-96
DOI 10.1016/j.schres.2021.08.004, PubMed 34454305
Characterisation of age and polarity at onset in bipolar disorder
Br J Psychiatry, 219 (6), 659-669
DOI 10.1192/bjp.2021.102, PubMed 35048876
DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis - A narrative review from the ECNP bipolar disorders network
Eur Neuropsychopharmacol, 47, 54-61
DOI 10.1016/j.euroneuro.2021.01.097, PubMed 33541809
Substance Misuse Trajectories and Risk of Relapse in the Early Course of Bipolar Disorder
Front Psychiatry, 12, 656912
DOI 10.3389/fpsyt.2021.656912, PubMed 34017275
Childhood trauma and cardiometabolic risk in severe mental disorders: The mediating role of cognitive control
Eur Psychiatry, 64 (1), e24
DOI 10.1192/j.eurpsy.2021.14, PubMed 33775258
Corrigendum to "Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action [European Neuropsychopharmacology (2020) 36, 121-136]"
Eur Neuropsychopharmacol, 44, 121-122
DOI 10.1016/j.euroneuro.2021.01.001, PubMed 33495109
Characterizing the Genetic Overlap Between Psychiatric Disorders and Sleep-Related Phenotypes
Biol Psychiatry, 90 (9), 621-631
DOI 10.1016/j.biopsych.2021.07.007, PubMed 34482950
Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review
Eur Neuropsychopharmacol, 54, 90-99
DOI 10.1016/j.euroneuro.2021.09.001, PubMed 34607722
Extensive bidirectional genetic overlap between bipolar disorder and cardiovascular disease phenotypes
Transl Psychiatry, 11 (1), 407
DOI 10.1038/s41398-021-01527-z, PubMed 34301917
Polygenic overlap and shared genetic loci between loneliness, severe mental disorders, and cardiovascular disease risk factors suggest shared molecular mechanisms
Transl Psychiatry, 11 (1), 3
DOI 10.1038/s41398-020-01142-4, PubMed 33414458
Evidence for Reduced Long-Term Potentiation-Like Visual Cortical Plasticity in Schizophrenia and Bipolar Disorder
Schizophr Bull, 47 (6), 1751-1760
DOI 10.1093/schbul/sbab049, PubMed 33963856
Publications 2020
Heart rate variability is associated with disease severity in psychosis spectrum disorders
Prog Neuropsychopharmacol Biol Psychiatry, 111, 110108
DOI 10.1016/j.pnpbp.2020.110108, PubMed 32946948
The genetic architecture of human brainstem structures and their involvement in common brain disorders
Nat Commun, 11 (1), 4016
DOI 10.1038/s41467-020-17376-1, PubMed 32782260
Polygenic scores for schizophrenia and general cognitive ability: associations with six cognitive domains, premorbid intelligence, and cognitive composite score in individuals with a psychotic disorder and in healthy controls
Transl Psychiatry, 10 (1), 416
DOI 10.1038/s41398-020-01094-9, PubMed 33257657
In vivo hippocampal subfield volumes in bipolar disorder-A mega-analysis from The Enhancing Neuro Imaging Genetics through Meta-Analysis Bipolar Disorder Working Group
Hum Brain Mapp, 43 (1), 385-398
DOI 10.1002/hbm.25249, PubMed 33073925
Disentangling the relationship between cholesterol, aggression, and impulsivity in severe mental disorders
Brain Behav, 10 (9), e01751
DOI 10.1002/brb3.1751, PubMed 32681586
Affective lability across psychosis spectrum disorders
Eur Psychiatry, 63 (1), e53
DOI 10.1192/j.eurpsy.2020.44, PubMed 32372737
Misperception of sleep in bipolar disorder: an exploratory study using questionnaire versus actigraphy
Int J Bipolar Disord, 8 (1), 34
DOI 10.1186/s40345-020-00198-x, PubMed 33215273
Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action
Eur Neuropsychopharmacol, 36, 121-136
DOI 10.1016/j.euroneuro.2020.05.006, PubMed 32536571
Cannabis Use Is Associated With Increased Levels of Soluble gp130 in Schizophrenia but Not in Bipolar Disorder
Front Psychiatry, 11, 642
DOI 10.3389/fpsyt.2020.00642, PubMed 32714224
Brain Age Prediction Reveals Aberrant Brain White Matter in Schizophrenia and Bipolar Disorder: A Multisample Diffusion Tensor Imaging Study
Biol Psychiatry Cogn Neurosci Neuroimaging, 5 (12), 1095-1103
DOI 10.1016/j.bpsc.2020.06.014, PubMed 32859549
Publications 2019
Widespread white matter microstructural abnormalities in bipolar disorder: evidence from mega- and meta-analyses across 3033 individuals
Neuropsychopharmacology, 44 (13), 2285-2293
DOI 10.1038/s41386-019-0485-6, PubMed 31434102
Correction: Widespread white matter microstructural abnormalities in bipolar disorder: evidence from mega- and meta-analyses across 3033 individuals
Neuropsychopharmacology, 44 (13), 2298
DOI 10.1038/s41386-019-0521-6, PubMed 31527792
Improvement in verbal learning over the first year of antipsychotic treatment is associated with serum HDL levels in a cohort of first episode psychosis patients
Eur Arch Psychiatry Clin Neurosci, 270 (1), 49-58
DOI 10.1007/s00406-019-01017-w, PubMed 31028479
Tobacco smoking and other substance use disorders associated with recurrent suicide attempts in bipolar disorder
J Affect Disord, 256, 348-357
DOI 10.1016/j.jad.2019.05.075, PubMed 31202989
Distinct structural brain circuits indicate mood and apathy profiles in bipolar disorder
Neuroimage Clin, 26, 101989
DOI 10.1016/j.nicl.2019.101989, PubMed 31451406
Sleep disturbances in schizophrenia spectrum and bipolar disorders - a transdiagnostic perspective
Compr Psychiatry, 91, 6-12
DOI 10.1016/j.comppsych.2019.02.006, PubMed 30856497
Cardiovascular risk remains high in schizophrenia with modest improvements in bipolar disorder during past decade
Acta Psychiatr Scand, 139 (4), 348-360
DOI 10.1111/acps.13008, PubMed 30697685
Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative
Int J Bipolar Disord, 7 (1), 20
DOI 10.1186/s40345-019-0156-x, PubMed 31552554
Childhood maltreatment and polygenic risk in bipolar disorders
Bipolar Disord, 22 (2), 174-181
DOI 10.1111/bdi.12851, PubMed 31628696
Publications 2018
Validity of the Birchwood insight scale in patients with schizophrenia spectrum- and bipolar disorders
Psychiatry Res, 272, 715-722
DOI 10.1016/j.psychres.2018.12.072, PubMed 30832191
Using structural MRI to identify bipolar disorders - 13 site machine learning study in 3020 individuals from the ENIGMA Bipolar Disorders Working Group
Mol Psychiatry, 25 (9), 2130-2143
DOI 10.1038/s41380-018-0228-9, PubMed 30171211
White matter aberrations and age-related trajectories in patients with schizophrenia and bipolar disorder revealed by diffusion tensor imaging
Sci Rep, 8 (1), 14129
DOI 10.1038/s41598-018-32355-9, PubMed 30237410
Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium
Biol Psychiatry, 84 (9), 644-654
DOI 10.1016/j.biopsych.2018.04.023, PubMed 29960671
Publications 2017
Neurocognitive functioning, clinical course and functional outcome in first-treatment bipolar I disorder patients with and without clinical relapse: A 1-year follow-up study
Bipolar Disord, 20 (3), 228-237
DOI 10.1111/bdi.12569, PubMed 29121444
Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis
Schizophr Res, 197, 253-260
DOI 10.1016/j.schres.2017.10.042, PubMed 29129510
Cortical thickness, cortical surface area and subcortical volumes in schizophrenia and bipolar disorder patients with cannabis use
Eur Neuropsychopharmacol, 28 (1), 37-47
DOI 10.1016/j.euroneuro.2017.11.019, PubMed 29254657
Cerebellar volume and cerebellocerebral structural covariance in schizophrenia: a multisite mega-analysis of 983 patients and 1349 healthy controls
Mol Psychiatry, 23 (6), 1512-1520
DOI 10.1038/mp.2017.106, PubMed 28507318
Impairment in emotion perception from body movements in individuals with bipolar I and bipolar II disorder is associated with functional capacity
Int J Bipolar Disord, 5 (1), 13
DOI 10.1186/s40345-017-0083-7, PubMed 28332121
Psychotic patients who used cannabis frequently before illness onset have higher genetic predisposition to schizophrenia than those who did not
Psychol Med, 48 (1), 43-49
DOI 10.1017/S0033291717001209, PubMed 28967348
Publications 2016
History of psychosis and previous episodes as potential explanatory factors for neurocognitive impairment in first-treatment bipolar I disorder
Bipolar Disord, 18 (2), 136-47
DOI 10.1111/bdi.12377, PubMed 26990158
Course of neurocognitive function in first treatment bipolar I disorder: One-year follow-up study
Psychiatry Res, 249, 286-292
DOI 10.1016/j.psychres.2016.12.048, PubMed 28142102
Task modulations and clinical manifestations in the brain functional connectome in 1615 fMRI datasets
Neuroimage, 147, 243-252
DOI 10.1016/j.neuroimage.2016.11.073, PubMed 27916665
Duration of untreated illness in first-treatment bipolar I disorder in relation to clinical outcome and cannabis use
Psychiatry Res, 246, 762-768
DOI 10.1016/j.psychres.2016.07.064, PubMed 27814886
Alcohol use disorders are associated with increased affective lability in bipolar disorder
J Affect Disord, 208, 316-324
DOI 10.1016/j.jad.2016.09.062, PubMed 27810713
Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder
Psychol Med, 46 (15), 3127-3136
DOI 10.1017/S0033291716001999, PubMed 27534999
VRK2 gene expression in schizophrenia, bipolar disorder and healthy controls
Br J Psychiatry, 209 (2), 114-20
DOI 10.1192/bjp.bp.115.161950, PubMed 26941264
An exploration of metacognitive beliefs and thought control strategies in bipolar disorder
Compr Psychiatry, 73, 84-92
DOI 10.1016/j.comppsych.2016.11.008, PubMed 27918949
Affective lability mediates the association between childhood trauma and suicide attempts, mixed episodes and co-morbid anxiety disorders in bipolar disorders
Psychol Med, 47 (5), 902-912
DOI 10.1017/S0033291716003081, PubMed 27894372
Publications 2015
Polygenic risk scores in bipolar disorder subgroups
J Affect Disord, 183, 310-4
DOI 10.1016/j.jad.2015.05.021, PubMed 26047958
Cannabis use is associated with 3years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119)
Schizophr Res, 170 (1), 217-21
DOI 10.1016/j.schres.2015.11.027, PubMed 26682958
Disintegration of Sensorimotor Brain Networks in Schizophrenia
Schizophr Bull, 41 (6), 1326-35
DOI 10.1093/schbul/sbv060, PubMed 25943122
Continued cannabis use at one year follow up is associated with elevated mood and lower global functioning in bipolar I disorder
BMC Psychiatry, 15, 11
DOI 10.1186/s12888-015-0389-x, PubMed 25651990
Cannabis use disorder is associated with greater illness severity in tobacco smoking patients with bipolar disorder
J Affect Disord, 190, 286-293
DOI 10.1016/j.jad.2015.10.023, PubMed 26544611
Delayed sleep phase: An important circadian subtype of sleep disturbance in bipolar disorders
J Affect Disord, 191, 156-63
DOI 10.1016/j.jad.2015.11.025, PubMed 26655861
Sleep problems in bipolar disorders: more than just insomnia
Acta Psychiatr Scand, 133 (5), 368-77
DOI 10.1111/acps.12523, PubMed 26590799
Publications 2014
Cannabis use in first-treatment bipolar I disorder: relations to clinical characteristics
Early Interv Psychiatry, 10 (1), 36-44
DOI 10.1111/eip.12138, PubMed 24739233
Psychometric properties of the Affective Lability Scale (54 and 18-item version) in patients with bipolar disorder, first-degree relatives, and healthy controls
J Affect Disord, 172, 375-80
DOI 10.1016/j.jad.2014.10.028, PubMed 25451440
Publications 2013
Neurocognitive features in subgroups of bipolar disorder
Bipolar Disord, 15 (3), 272-83
DOI 10.1111/bdi.12061, PubMed 23521608
Indications of a dose-response relationship between cannabis use and age at onset in bipolar disorder
Psychiatry Res, 215 (1), 101-4
DOI 10.1016/j.psychres.2013.10.029, PubMed 24262665
Patterns of childhood adverse events are associated with clinical characteristics of bipolar disorder
BMC Psychiatry, 13, 97
DOI 10.1186/1471-244X-13-97, PubMed 23522391
Publications 2012
An association between affective lability and executive functioning in bipolar disorder
Psychiatry Res, 198 (1), 58-61
DOI 10.1016/j.psychres.2011.12.044, PubMed 22405635
Neurocognitive functioning in patients recently diagnosed with bipolar disorder
Bipolar Disord, 14 (3), 227-38
DOI 10.1111/j.1399-5618.2012.01004.x, PubMed 22548896
High prevalence of childhood trauma in patients with schizophrenia spectrum and affective disorder
Compr Psychiatry, 54 (2), 123-7
DOI 10.1016/j.comppsych.2012.06.009, PubMed 22901835
Publications 2011
Perceived discrimination is associated with severity of positive and depression/anxiety symptoms in immigrants with psychosis: a cross-sectional study
BMC Psychiatry, 11, 77
DOI 10.1186/1471-244X-11-77, PubMed 21548949
Verbal learning contributes to cognitive insight in schizophrenia independently of affective and psychotic symptoms
Prog Neuropsychopharmacol Biol Psychiatry, 35 (4), 1059-63
DOI 10.1016/j.pnpbp.2011.02.021, PubMed 21392553
Substance use in bipolar disorder: associations with age at onset, treatment delay and outcome
In Series of dissertations submitted to the Faculty of Social Sciences, University of Oslo, Unipub, Oslo, no. 249, 1 b. (flere pag.)
BIBSYS 111814049
Excessive cannabis use is associated with earlier age at onset in bipolar disorder
Eur Arch Psychiatry Clin Neurosci, 261 (6), 397-405
DOI 10.1007/s00406-011-0188-4, PubMed 21267743
Sex-specific cortisol levels in bipolar disorder and schizophrenia during mental challenge--relationship to clinical characteristics and medication
Prog Neuropsychopharmacol Biol Psychiatry, 35 (4), 1100-7
DOI 10.1016/j.pnpbp.2011.03.008, PubMed 21420462
Publications 2010
Decreased self-reported arousal in schizophrenia during aversive picture viewing compared to bipolar disorder and healthy controls
Psychiatry Res, 185 (3), 309-14
DOI 10.1016/j.psychres.2010.07.026, PubMed 20724003
Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study
BMC Psychiatry, 10, 9
DOI 10.1186/1471-244X-10-9, PubMed 20105311
Treatment delay and excessive substance use in bipolar disorder
J Nerv Ment Dis, 198 (9), 628-33
DOI 10.1097/NMD.0b013e3181ef3ef4, PubMed 20823723
Publications 2009
Age at onset of bipolar disorder in a Norwegian catchment area sample
J Affect Disord, 124 (1-2), 174-7
DOI 10.1016/j.jad.2009.10.031, PubMed 19931918
Publications 2007
Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder
Psychol Med, 38 (9), 1241-9
DOI 10.1017/S003329170700236X, PubMed 18070373